Market Movers

Henry Schein, Inc.’s Stock Price Drops to $72.55, Witnessing a 4.32% Decrease: Time to Sell or Buy?

By February 27, 2025 No Comments

Henry Schein, Inc. (HSIC)

72.55 USD -3.27 (-4.32%) Volume: 3.9M

Henry Schein, Inc.’s stock price is currently trading at 72.55 USD, experiencing a downturn of -4.32% this trading session, despite a positive YTD change of +4.83%. With a trading volume of 3.9M, HSIC’s stock performance continues to capture the attention of investors.


Latest developments on Henry Schein, Inc.

Henry Schein, Inc. has been making headlines recently with a series of key events impacting its stock price. From reporting strong global sales growth during its Q4 2024 earnings call, to analysts adjusting price targets and ratings, the company has been in the spotlight. Despite meeting Q4 earnings estimates, Henry Schein’s profit outlook took a hit amid weak dental demand, leading to a restructure for future growth. Insiders selling shares and sales below analyst estimates have also contributed to stock price movements. With nominations open for the Athletics and Schools 2025 Rising Star Award, the company is looking towards the future with expectations of strong performance in 2025.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars